239 related articles for article (PubMed ID: 23716562)
41. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
[TBL] [Abstract][Full Text] [Related]
42. Molecular genetics of peripheral T-cell lymphomas.
Piccaluga PP; Tabanelli V; Pileri SA
Int J Hematol; 2014 Mar; 99(3):219-26. PubMed ID: 24481943
[TBL] [Abstract][Full Text] [Related]
43. Current Concepts in Nodal Peripheral T-Cell Lymphomas.
Oishi N; Feldman AL
Surg Pathol Clin; 2023 Jun; 16(2):267-285. PubMed ID: 37149360
[TBL] [Abstract][Full Text] [Related]
44. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.
Oschlies I; Lisfeld J; Lamant L; Nakazawa A; d'Amore ES; Hansson U; Hebeda K; Simonitsch-Klupp I; Maldyk J; Müllauer L; Tinguely M; Stücker M; Ledeley MC; Siebert R; Reiter A; Brugières L; Klapper W; Woessmann W
Haematologica; 2013 Jan; 98(1):50-6. PubMed ID: 22773605
[TBL] [Abstract][Full Text] [Related]
45. Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators.
van Kester MS; Tensen CP; Vermeer MH; Dijkman R; Mulder AA; Szuhai K; Willemze R; van Doorn R
J Invest Dermatol; 2010 Feb; 130(2):563-75. PubMed ID: 19710685
[TBL] [Abstract][Full Text] [Related]
46. Frequent expression of CD30 antigen in the primary gastric non-B, non-Hodgkin lymphomas.
Iwamizu-Watanabe S; Yamashita Y; Yatabe Y; Nakamura S; Mori N
Pathol Int; 2004 Jul; 54(7):503-9. PubMed ID: 15189504
[TBL] [Abstract][Full Text] [Related]
47. CD69 expression correlates with expression of other markers of Th1 T cell differentiation in peripheral T cell lymphomas.
Dorfman DM; Shahsafaei A
Hum Pathol; 2002 Mar; 33(3):330-4. PubMed ID: 11979374
[TBL] [Abstract][Full Text] [Related]
48. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients.
Beljaards RC; Kaudewitz P; Berti E; Gianotti R; Neumann C; Rosso R; Paulli M; Meijer CJ; Willemze R
Cancer; 1993 Mar; 71(6):2097-104. PubMed ID: 8382999
[TBL] [Abstract][Full Text] [Related]
49. Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas.
Di Napoli A; De Cecco L; Piccaluga PP; Navari M; Cancila V; Cippitelli C; Pepe G; Lopez G; Monardo F; Bianchi A; D'Amore ESG; Gianelli U; Facchetti F; Berti E; Bhagat G
Mod Pathol; 2019 Feb; 32(2):216-230. PubMed ID: 30206415
[TBL] [Abstract][Full Text] [Related]
50. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
[TBL] [Abstract][Full Text] [Related]
51. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
Eckerle S; Brune V; Döring C; Tiacci E; Bohle V; Sundström C; Kodet R; Paulli M; Falini B; Klapper W; Chaubert AB; Willenbrock K; Metzler D; Bräuninger A; Küppers R; Hansmann ML
Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
[TBL] [Abstract][Full Text] [Related]
52. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
[TBL] [Abstract][Full Text] [Related]
53. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
[TBL] [Abstract][Full Text] [Related]
54. The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.
Boddicker RL; Kip NS; Xing X; Zeng Y; Yang ZZ; Lee JH; Almada LL; Elsawa SF; Knudson RA; Law ME; Ketterling RP; Cunningham JM; Wu Y; Maurer MJ; O'Byrne MM; Cerhan JR; Slager SL; Link BK; Porcher JC; Grote DM; Jelinek DF; Dogan A; Ansell SM; Fernandez-Zapico ME; Feldman AL
Blood; 2015 May; 125(20):3118-27. PubMed ID: 25833963
[TBL] [Abstract][Full Text] [Related]
55. Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL).
Janikova A; Michalka J; Chloupkova R; Kopalova N; Campr V; Kamaradova K; Kren L; Belada D; Benesova K; Dlouha J; Klener P; Procházka V; Mocikova H; Duras J; Trneny M
Ann Hematol; 2022 Apr; 101(4):789-798. PubMed ID: 35061088
[TBL] [Abstract][Full Text] [Related]
56. Relation of CD30 expression to survival and morphology in large cell B cell lymphomas.
Noorduyn LA; de Bruin PC; van Heerde P; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
J Clin Pathol; 1994 Jan; 47(1):33-7. PubMed ID: 8132806
[TBL] [Abstract][Full Text] [Related]
57. CD30 positive (non-anaplastic) peripheral T-cell lymphoma of the thyroid gland.
Forconi F; Bocchia M; Marconcini S; Bigazzi C; Milani M; Fraternali-Orcioni G; Lauria F
Haematologica; 1999 Oct; 84(10):946-8. PubMed ID: 10509044
[TBL] [Abstract][Full Text] [Related]
58. Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma.
Watanabe M; Itoh K; Togano T; Kadin ME; Watanabe T; Higashihara M; Horie R
Am J Pathol; 2012 Feb; 180(2):831-8. PubMed ID: 22107829
[TBL] [Abstract][Full Text] [Related]
59. Ukraine Data on Prognostic Factors and Treatment Outcomes in Patients with Peripheral T-Cell Lymphomas.
Skrypets T; Novosad O; Pastushenko Y; Gorbach O; Kriachok I
Klin Onkol; 2019; 32(6):436-444. PubMed ID: 31842562
[TBL] [Abstract][Full Text] [Related]
60. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
